White matter hyperintensities in cholinergic pathways may predict poorer responsiveness to acetylcholinesterase inhibitor treatment for Alzheimer’s disease

BACKGROUND: Acetylcholinesterase inhibitor (AChEI) drug regimens are the mainstay treatment options for patients with Alzheimer’s disease (AD). Herein, We examined the association between clinical response to AChEI and white matter hyperintensities on magnetic resonance imaging (MRI) scan at baselin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Li-Hua, Wu, Shu-Ching, Ho, Cheng-Feng, Liang, Wan-Lin, Liu, Yi-Chien, Chou, Chia-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065432/
https://www.ncbi.nlm.nih.gov/pubmed/37000849
http://dx.doi.org/10.1371/journal.pone.0283790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065432/
https://www.ncbi.nlm.nih.gov/pubmed/37000849
http://dx.doi.org/10.1371/journal.pone.0283790

Ejemplares similares